ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
11.85
+0.03 (0.25%)
Nov 28, 2025, 4:00 PM EST - Market closed

ORIC Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
1,1545695022655791,240
Upgrade
Market Cap Growth
58.83%13.47%89.55%-54.26%-53.31%-
Upgrade
Enterprise Value
877307285843021,053
Upgrade
Last Close Price
11.888.079.205.8914.7033.85
Upgrade
PB Ratio
2.842.342.241.192.124.28
Upgrade
P/TBV Ratio
2.842.342.241.192.124.28
Upgrade
Debt / Equity Ratio
0.020.040.050.050.05-
Upgrade
Quick Ratio
14.2310.3010.1813.4115.6432.62
Upgrade
Current Ratio
14.6510.5610.3913.6815.8832.96
Upgrade
Return on Equity (ROE)
-39.73%-54.73%-45.11%-35.98%-27.98%-39.02%
Upgrade
Return on Assets (ROA)
-25.23%-33.95%-27.74%-19.87%-16.50%-15.69%
Upgrade
Return on Capital (ROIC)
-26.50%-36.69%-29.54%-20.86%-17.14%-16.33%
Upgrade
Return on Capital Employed (ROCE)
-36.00%-57.30%-47.80%-37.40%-27.80%-17.00%
Upgrade
Earnings Yield
-11.69%-22.45%-20.06%-33.66%-13.60%-5.94%
Upgrade
FCF Yield
-10.13%-19.99%-17.24%-29.17%-10.45%-3.70%
Upgrade
Buyback Yield / Dilution
-20.05%-35.52%-29.74%-4.48%-72.97%-1055.26%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q